UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International clinical psychopharmacology, ISSN 0268-1315, 07/2014, Volume 29, Issue 4, pp. 185 - 196
allosteric | selective serotonin reuptake inhibitor | serotonin | paroxetine | major depressive disorder | serotonin transporter | escitalopram (S-citalopram) | sertraline | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Paroxetine - pharmacokinetics | Antidepressive Agents, Second-Generation - adverse effects | Antidepressive Agents, Second-Generation - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Citalopram - pharmacology | Depressive Disorder, Major - metabolism | Humans | Citalopram - adverse effects | Paroxetine - therapeutic use | Sertraline - adverse effects | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Depression - drug therapy | Serotonin Plasma Membrane Transport Proteins - chemistry | Depression - metabolism | Nerve Tissue Proteins - chemistry | Drug Interactions | Sertraline - pharmacokinetics | Sertraline - therapeutic use | Depressive Disorder, Major - drug therapy | Nerve Tissue Proteins - antagonists & inhibitors | Sertraline - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Antidepressive Agents, Second-Generation - pharmacology | Evidence-Based Medicine | Nerve Tissue Proteins - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Animals | Models, Biological | Allosteric Site | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Paroxetine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Index Medicus | Review
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2019, Volume 321, Issue 6, pp. 588 - 601
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Behavior Therapy | Humans | Risk Factors | Sertraline - adverse effects | Antidepressive Agents - therapeutic use | Pregnancy | Depression, Postpartum - prevention & control | Depression - prevention & control | Counseling | Sertraline - therapeutic use | Female | Referral and Consultation | Antidepressive Agents - adverse effects | Pregnancy Complications - prevention & control | Prevention | Research | Depression, Mental | Risk assessment | Analysis | Risk factors | Intervention | Health care | Medical research | Signs and symptoms | Statistical analysis | Dietary supplements | Clinical trials | Risk reduction | Prenatal depression | Risk | Systematic review | Mental depression | Sertraline | Childbirth & labor | Side effects | Reduction | Diet | Antidepressants | Postpartum depression | Risk management | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9789, pp. 403 - 411
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Mianserin - adverse effects | Alzheimer Disease - complications | Double-Blind Method | Humans | Mianserin - therapeutic use | Depressive Disorder - drug therapy | Male | Mental Disorders - complications | Sertraline - adverse effects | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Mianserin - analogs & derivatives | Dementia - complications | Depressive Disorder - complications | Mental Disorders - drug therapy | Sertraline - therapeutic use | Aged, 80 and over | Mirtazapine | Female | Aged | Antidepressive Agents - adverse effects | Drug therapy | Comparative analysis | Sertraline | Health aspects | Depression, Mental | Dementia | Medical research | Antidepressants | Workers | Meetings | Health services | Mortality | Mental health | Clinical trials | Clinical medicine | Alzheimers disease | Index Medicus | Abridged Index Medicus | Drugs | Neurodegenerative diseases | Suicide | Side effects | technology assessment | Dementia disorders | Models | Alzheimer's disease | Psychiatry | sertraline
Journal Article
Brain, behavior, and immunity, ISSN 0889-1591, 2012, Volume 31, pp. 143 - 152
Psychiatry | Allergy and Immunology | Oxidative stress | F2-isoprostane | Depression | Inflammation | Oxidation | Sertraline | IL-6 | IL-10 | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Sertraline - pharmacology | Depressive Disorder, Major - metabolism | Humans | Middle Aged | Oxidative Stress - physiology | Interleukin-10 - blood | Male | Treatment Outcome | Antidepressive Agents - therapeutic use | Inflammation - metabolism | Interleukin-6 - blood | Sertraline - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Oxidative Stress - drug effects | Depressive Disorder, Major - drug therapy | Major depressive disorder | Index Medicus
Journal Article
Environmental toxicology and chemistry, ISSN 0730-7268, 02/2005, Volume 24, Issue 2, pp. 464 - 469
Fluoxetine | Sertraline | Environmental pharmaceuticals | Municipal effluent | Environmental Sciences & Ecology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Environmental Sciences | Fundamental and applied biological sciences. Psychology | General aspects | Synecology | Fresh water ecosystems | Animal, plant and microbial ecology | Biological and medical sciences | Animal and plant ecology | Applied ecology | Ecotoxicology, biological effects of pollution | Serotonin Uptake Inhibitors - metabolism | Antidepressive Agents - blood | Antidepressive Agents - analysis | Liver - metabolism | Sertraline - blood | Rivers | Water Pollutants, Chemical - analysis | Fluoxetine - blood | Antidepressive Agents - toxicity | Brain - metabolism | Sertraline - analogs & derivatives | Animals | Water Pollutants, Chemical - toxicity | Time Factors | Fishes | Fluoxetine - analogs & derivatives | Fluoxetine - metabolism | Serotonin Uptake Inhibitors - blood | Muscles - metabolism | Sertraline - metabolism | Creeks & streams | Fish | Antidepressants | Effluents | Aquatic ecosystems | Pharmaceuticals | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2002, Volume 288, Issue 6, pp. 701 - 709
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Depressive Disorder, Major - etiology | Double-Blind Method | Myocardial Infarction - psychology | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Male | Treatment Outcome | Hospitalization | Sertraline - adverse effects | Angina, Unstable - psychology | Sertraline - therapeutic use | Female | Depressive Disorder, Major - drug therapy | Psychological aspects | Evaluation | Drug therapy | Sertraline | Depression, Mental | Cardiac patients | Clinical trials | Cardiovascular disease | Mental depression | Angina pectoris | Antidepressants | Index Medicus | Abridged Index Medicus | Sertraline/adverse effects/therapeutic use | Serotonin Uptake Inhibitors/adverse effects/therapeutic use | Depressive Disorder | Angina | Unstable/psychology | Kardiologi | Cardiac and Cardiovascular Systems | Myocardial Infarction/psychology | Major/drug therapy/etiology
Journal Article
Journal of developmental and behavioral pediatrics, ISSN 0196-206X, 10/2016, Volume 37, Issue 8, pp. 619 - 628
SSRI | treatment | ASD | Index terms: fragile X syndrome | autism | sertraline | Pediatrics | Social Sciences | Life Sciences & Biomedicine | Behavioral Sciences | Psychology | Psychology, Developmental | Science & Technology | Outcome Assessment (Health Care) - methods | Sertraline - pharmacology | Double-Blind Method | Humans | Child, Preschool | Serotonin Uptake Inhibitors - adverse effects | Male | Sertraline - adverse effects | Fragile X Syndrome - drug therapy | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Female | Serotonin Uptake Inhibitors - pharmacology | Child | Clinical trials | Genetic disorders | Antidepressants | Placebo effect | Children & youth | Index Medicus
Journal Article